NEW YORK (GenomeWeb) – Sigma-Aldrich today reported a 2 percent increase in its first-quarter sales as the firm fell short of the consensus analyst estimate on the top line but exceeded it on the bottom line.

For the three months ended March 31, the company reported sales of $689 million, up from $675 million in the year-ago quarter. Analysts had expected on average $690.6 million.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.